EditorialEditorial
Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
MOISES LABRADOR-HORRILLO and ALBERT SELVA-O’CALLAGHAN
The Journal of Rheumatology June 2018, 45 (6) 731-732; DOI: https://doi.org/10.3899/jrheum.180007
MOISES LABRADOR-HORRILLO
Systemic Autoimmune Diseases Unit, Vall D’Hebron General Hospital, Internal Medicine Department, Universitat Autonoma de Barcelona, Barcelona,
Spain.
MD, PhDRoles: Associate Professor
ALBERT SELVA-O’CALLAGHAN
Systemic Autoimmune Diseases Unit, Vall D’Hebron General Hospital, Internal Medicine Department, Universitat Autonoma de Barcelona, Barcelona,
Spain.
MD, PhDRoles: Professor
REFERENCES
- 1.↵
- 2.↵
- Aussy A,
- Boyer O,
- Cordel N
- 3.↵
- Schreiber RD,
- Old LJ,
- Smyth MJ
- 4.↵
- Pinal-Fernandez I,
- Ferrer-Fabregas B,
- Trallero-Araguas E,
- Balada E,
- Martínez MA,
- Milisenda JC,
- et al.
- 5.↵
- 6.↵
- Labrador-Horrillo M,
- Martínez MA,
- Selva-O’Callaghan A,
- Trallero-Araguás E,
- Balada E,
- Vilardell-Tarrés M,
- et al.
- 7.↵
- Joseph CG,
- Darrah E,
- Shah AA,
- Skora AD,
- Casciola-Rosen LA,
- Wigley FM,
- et al.
- 8.↵
- Chen H,
- Peng Q,
- Yang H,
- Yin L,
- Shi J,
- Zhang Y,
- et al.
- 9.↵
- 10.↵
- 11.↵
- Liewluck T,
- Kao JC,
- Mauermann ML
- 12.↵
- Ding Y,
- Sun C,
- Li J,
- Hu L,
- Li M,
- Liu J,
- et al.
In this issue
The Journal of Rheumatology
Vol. 45, Issue 6
1 Jun 2018
Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
MOISES LABRADOR-HORRILLO, ALBERT SELVA-O’CALLAGHAN
The Journal of Rheumatology Jun 2018, 45 (6) 731-732; DOI: 10.3899/jrheum.180007